DSpace Repository

Effect of nepafenac 0.1% on retinal thickness after cataract surgery in patients without risk factors for cystoid macular edema

Show simple item record

dc.contributor.author Sahin, Asena Keles
dc.contributor.author Kukner, Ahmet Sahap
dc.contributor.author Ulas, Fatih
dc.contributor.author Dogan, Umit
dc.date.accessioned 2024-03-15T12:05:45Z
dc.date.available 2024-03-15T12:05:45Z
dc.date.issued 2020
dc.identifier.citation Sahin, AK., Kükner, AS., Ulas, F., Dogan, Ü. (2020). Effect of nepafenac 0.1% on retinal thickness after cataract surgery in patients without risk factors for cystoid macular edema. Int. J. Ophthalmol., 13(12), 1901-1907. https://doi.org/10.18240/ijo.2020.12.09 en_US
dc.identifier.issn 2222-3959
dc.identifier.issn 2227-4898
dc.identifier.uri http://dx.doi.org/10.18240/ijo.2020.12.09
dc.identifier.uri https://www.webofscience.com/wos/woscc/full-record/WOS:000596627600009
dc.identifier.uri http://earsiv.odu.edu.tr:8080/xmlui/handle/11489/4629
dc.description WoS Categories: Ophthalmology en_US
dc.description Web of Science Index: Science Citation Index Expanded (SCI-EXPANDED) en_US
dc.description Research Areas: Ophthalmology en_US
dc.description.abstract AIM: To evaluate the effect of topical preoperative nepafenac 0.1% treatment on postoperative macular edema using optical coherence tomography (OCT) after uncomplicated cataract surgery. METHODS: Ninety eyes of 90 patients without any risk factors were included in the study. The patients were assigned to three groups: group 1, treated with topical prednisolone acetate 1%; group 2, treated with topical nepafenac 0.1% in addition to prednisolone acetate (1%); and group 3, those who started receiving nepafenac 0.1% treatment 3d prior to surgery and continued the treatment postoperatively in addition to prednisolone acetate (1%). Central retinal thickness (CRT) and macular volume values were recorded using OCT at weeks 3 and 6. RESULTS: The increases in macular volume in the central 1 mm area after 3 and 6wk were significantly lower in patients who used prophylactic topical nepafenac preoperatively (group 3) compared with those in group 1 (P=0.028 and 0.008, respectively). No significant differences in the increase in macular volume and CRT were noted between groups 2 and 3 (P>0.05). In group 1, the increases in macular volume in the central 3 mm area at weeks 3 and 6 were significantly higher than that in group 2 and 3 (3rd week, P=0.004; 6th week, P=0.005). CONCLUSION: Nepafenac 0.1% treatment in addition to topical steroids after uncomplicated cataract surgery reduce the increase in macular volume in the early postoperative period. en_US
dc.language.iso eng en_US
dc.publisher IJO PRESS-XI AN en_US
dc.relation.isversionof 10.18240/ijo.2020.12.09 en_US
dc.rights info:eu-repo/semantics/openAccess en_US
dc.subject cataract surgery, cystoid macular edema, nepafenac, optic coherence tomography, retinal thickness en_US
dc.subject NONSTEROIDAL ANTIINFLAMMATORY DRUGS, KETOROLAC 0.4-PERCENT, VISUAL-ACUITY, DEXAMETHASONE, PREVENTION, INFLAMMATION, MANAGEMENT, BROMFENAC, EFFICACY, IMPACT en_US
dc.title Effect of nepafenac 0.1% on retinal thickness after cataract surgery in patients without risk factors for cystoid macular edema en_US
dc.type article en_US
dc.relation.journal INTERNATIONAL JOURNAL OF OPHTHALMOLOGY en_US
dc.contributor.department Ordu Üniversitesi en_US
dc.contributor.authorID 0000-0003-4468-3985 en_US
dc.identifier.volume 13 en_US
dc.identifier.issue 12 en_US
dc.identifier.startpage 1901 en_US
dc.identifier.endpage 1907 en_US


Files in this item

Files Size Format View

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record

Search DSpace


Advanced Search

Browse

My Account